Yu Bin, Wang Zhong
Department of Urology, the Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200011, China.
Zhonghua Nan Ke Xue. 2007 Aug;13(8):739-43.
The therapeutic options for benign prostatic hyperplasia (BPH) can be divided into medicinal, surgical and minimally invasive treatments. The minimally invasive treatment of BPH is gradually accepted by more and more urologists for its advantages of less damage, good effect, quick recovery and easy acceptance by patients, which includes transurethral needle ablation of the prostate (TUNA), transurethral microwave therapy (TUMT), photoselective laser vaporization of the prostate (PVP), holmium laser enucleation of the prostate (HOLEP) and so on. This article updates the advances in the minimally invasive treatment.
良性前列腺增生(BPH)的治疗选择可分为药物治疗、手术治疗和微创治疗。BPH的微创治疗因其损伤小、效果好、恢复快且易被患者接受等优点,逐渐被越来越多的泌尿外科医生所接受,包括经尿道前列腺针刺消融术(TUNA)、经尿道微波热疗(TUMT)、选择性光热汽化术(PVP)、钬激光前列腺剜除术(HOLEP)等。本文更新了微创治疗的进展。